{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T19:27:00Z","timestamp":1760383620008},"reference-count":52,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[1998,5,1]],"date-time":"1998-05-01T00:00:00Z","timestamp":893980800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[1998,5]]},"DOI":"10.1016\/s0278-5846(98)00033-5","type":"journal-article","created":{"date-parts":[[2002,7,25]],"date-time":"2002-07-25T09:23:42Z","timestamp":1027589022000},"page":"693-707","source":"Crossref","is-referenced-by-count":22,"title":["Medial prefrontal cortical D2 and striatolimbic D4 dopamine receptors: Common targets for typical and atypical antepsychotic drugs"],"prefix":"10.1016","volume":"22","author":[{"given":"Frank I.","family":"Tarazi","sequence":"first","affiliation":[]},{"given":"Sylva K.","family":"Yeghiayan","sequence":"additional","affiliation":[]},{"given":"John L.","family":"Neumeyer","sequence":"additional","affiliation":[]},{"given":"Ross J.","family":"Baldessarini","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/S0278-5846(98)00033-5_BIB1","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/0166-2236(89)90074-X","article-title":"The functional anatomy of basal ganglia disorders","volume":"12","author":"Albin","year":"1989","journal-title":"Trends Neurosci."},{"key":"10.1016\/S0278-5846(98)00033-5_BIB2","first-page":"162","article-title":"Dopamine neurochemical profile of atypical neuroleptics resembles that of D1 antagonists","volume":"338","author":"Altar","year":"1988","journal-title":"Naunyn-Schmiedeberg's Arch. Pharrnacol."},{"key":"10.1016\/S0278-5846(98)00033-5_BIB3","series-title":"Goodman and Gilman's The Pharmacological Basis of Therapeutics","first-page":"399","article-title":"Drugs and the treatment of psychiatric disorders","author":"Baldessarini","year":"1996"},{"key":"10.1016\/S0278-5846(98)00033-5_BIB4","series-title":"The Dopamine Receptors","first-page":"457","article-title":"Dopamine receptors and clinical medicine","author":"Baldessarini","year":"1997"},{"key":"10.1016\/S0278-5846(98)00033-5_BIB5","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/0304-3940(94)90098-1","article-title":"Effects of aporphine isomers on rat prolactin","volume":"176","author":"Baldessarini","year":"1994","journal-title":"Neurosci. Lett."},{"key":"10.1016\/S0278-5846(98)00033-5_BIB6","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1056\/NEJM199103143241107","article-title":"Clozapine-a novel antipsychotic agent","volume":"324","author":"Baldessarini","year":"1991","journal-title":"New Engl. J. Med."},{"key":"10.1016\/S0278-5846(98)00033-5_BIB7","doi-asserted-by":"crossref","first-page":"301","DOI":"10.3109\/10673229609017200","article-title":"Brain dopamine receptors: a primer on their current status, basic and clinical","volume":"3","author":"Baldessarini","year":"1996","journal-title":"Harvard Rev. Psychiatry"},{"key":"10.1016\/S0278-5846(98)00033-5_BIB8","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1001\/archpsyc.1997.01830200095014","article-title":"Clozapine withdrawal: Serotonergic or dopaminergic mechanisms-reply","volume":"54","author":"Baldessarini","year":"1997","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/S0278-5846(98)00033-5_BIB9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0074-7742(08)60636-4","article-title":"Relationship of the actions of neuroleptic drugs to the pathophysiology of tardive dyskinesia","volume":"21","author":"Baldessarini","year":"1979","journal-title":"Intl. Rev. Neurobiol."},{"key":"10.1016\/S0278-5846(98)00033-5_BIB10","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0166-2236(91)90179-X","article-title":"Dopaminergic innervation of the cerebral cortex: unexpected differences between rodents and primates","volume":"14","author":"Berger","year":"1991","journal-title":"Trends Neurosci."},{"key":"10.1016\/S0278-5846(98)00033-5_BIB11","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1007\/BF00652233","article-title":"Behavioral effects of apomorphine isomers in the rat: selective locomotor-inhibitory effects of S(+)N-n-propylnor-apomorphine","volume":"88","author":"Campbell","year":"1986","journal-title":"Psychopharmacology"},{"key":"10.1016\/S0278-5846(98)00033-5_BIB12","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/BF02244285","article-title":"Selective antidopaminergic effects of S(+)-N-propylnoraporphines in limbic vs extrapyramidal sites in rat brain: Comparisons with typical and atypical antipsychotic agents","volume":"103","author":"Campbell","year":"1991","journal-title":"Psychopharmacology"},{"key":"10.1016\/S0278-5846(98)00033-5_BIB13","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/BF02244952","article-title":"Altered spontaneous behavior and sensitivity to apomorphine in rats following treatment with S(+)-aporphines or fluphenazine","volume":"111","author":"Campbell","year":"1993","journal-title":"Psychopharmacology"},{"key":"10.1016\/S0278-5846(98)00033-5_BIB14","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/BF02244960","article-title":"Dopamine D1 (SCH23390) and D2 (haloperidol) antagonists in drug-naive monkeys","volume":"107","author":"Casey","year":"1992","journal-title":"Psychopharmacology"},{"key":"10.1016\/S0278-5846(98)00033-5_BIB15","first-page":"769","article-title":"Acute extrapyramidal syndrome in cebus monkeys: development mediated by dopamine D2 but not dopamine D1 receptors","volume":"249","author":"Coffin","year":"1989","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/S0278-5846(98)00033-5_BIB16","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1126\/science.3854","article-title":"Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs","volume":"192","author":"Crees","year":"1976","journal-title":"Science"},{"key":"10.1016\/S0278-5846(98)00033-5_BIB17","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/BF02246070","article-title":"Open trial of the D1 antagonist SCH 39166 in six cases of acute psychotic states","volume":"121","author":"Debeaurepaire","year":"1995","journal-title":"Psychopharmacology"},{"key":"10.1016\/S0278-5846(98)00033-5_BIB18","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/BF02244961","article-title":"Selective D1- and D2-dopamine receptor blockade both induce akathisia in humans-a PET study with [11C]SCH23390 and [11C]raclopride","volume":"107","author":"Farde","year":"1992","journal-title":"Psychopharmacology"},{"key":"10.1016\/S0278-5846(98)00033-5_BIB19","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1007\/BF00442555","article-title":"D1- and D2-dopamine receptor occupancy during treatment with conventional and atypical neuroleptics","volume":"99","author":"Farde","year":"1989","journal-title":"Psychopharmacology"},{"key":"10.1016\/S0278-5846(98)00033-5_BIB20","first-page":"561","article-title":"Dopamine receptor subtypes: Differential regulation after eight months treatment with antipsychotic drugs","volume":"280","author":"Florijn","year":"1997","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/S0278-5846(98)00033-5_BIB21","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/0165-6147(90)90147-Z","article-title":"Dopamine D1 receptor antagonism in schizophrenia: is there a reduced risk of extrapyramidal side-effects?","volume":"11","author":"Hietala","year":"1990","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/S0278-5846(98)00033-5_BIB22","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S1359-6446(97)01075-1","article-title":"Compounds selective for dopamine receptor subtypes","volume":"2","author":"Kebabian","year":"1997","journal-title":"Drug Discovery Today"},{"key":"10.1016\/S0278-5846(98)00033-5_BIB23","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0014-2999(97)01065-0","article-title":"RBI-257: A highly potent D4-selective dopamine receptor ligand","volume":"331","author":"Kula","year":"1997","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/S0278-5846(98)00033-5_BIB24","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1021\/jm9600712","article-title":"3-[[4-(4-Chlorophenyl)-piperazin-1-yl]-methyl]-1H-pyrrolo[2,3-b]pyridine: An antagonist with high affinity and selectivity for the human dopamine D4 receptor","volume":"39","author":"Kulagowski","year":"1996","journal-title":"J. Med. Chem."},{"key":"10.1016\/S0278-5846(98)00033-5_BIB25","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1097\/00001756-199608120-00016","article-title":"D2-type dopamine receptors in postmortem human brain sections from normal and schizophrenic subjects","volume":"7","author":"Lahti","year":"1996","journal-title":"NeuroReport"},{"key":"10.1016\/S0278-5846(98)00033-5_BIB26","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1097\/00001756-199512150-00015","article-title":"D2-Family receptor distribution in human postmortem tissue: An autoradiographic study","volume":"6","author":"Lahti","year":"1995","journal-title":"NeuroReport"},{"key":"10.1016\/S0278-5846(98)00033-5_BIB27","doi-asserted-by":"crossref","first-page":"R11","DOI":"10.1016\/0014-2999(96)00127-6","article-title":"Affinities and intrinsic activities of dopamine receptor agonists for the hD2L and hD4.4 receptors","volume":"301","author":"Lahti","year":"1996","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/S0278-5846(98)00033-5_BIB28","first-page":"4353","article-title":"A common action of clozapine, haloperidol, and remoxipride on D1- and D2-dopaminergic receptors in the primate cerebral cortex","volume":"91","author":"Lidow","year":"1994"},{"key":"10.1016\/S0278-5846(98)00033-5_BIB29","first-page":"749","article-title":"Unique binding characteristics of antipsychotic agents interacting with human dopamine D2A, D2B and D3 receptors","volume":"43","author":"Malmberg","year":"1993","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/S0278-5846(98)00033-5_BIB30","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0893-133X(95)00150-C","article-title":"Dopamine receptor mRNA expression in human striatum and neocortex","volume":"15","author":"Meador-Woodruff","year":"1996","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/S0278-5846(98)00033-5_BIB31","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1038\/342926a0","article-title":"Multiple D2 dopamine receptors produced by alternative RNA slicing","volume":"342","author":"Monsma","year":"1989","journal-title":"Nature"},{"key":"10.1016\/S0278-5846(98)00033-5_BIB32","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1523\/JNEUROSCI.15-03-02186.1995","article-title":"Distribution of putative D4 dopamine receptors in postmortem striatum from patients with schizophrenia","volume":"15","author":"Murray","year":"1995","journal-title":"J. Neurosci."},{"key":"10.1016\/S0278-5846(98)00033-5_BIB33","first-page":"27","article-title":"Effects of aporphine isomers and haloperidol on regional concentrations of neurotensin in rat brain","volume":"4","author":"Nemeroff","year":"1991","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/S0278-5846(98)00033-5_BIB34","series-title":"The Dopamine Receptors","year":"1997"},{"key":"10.1016\/S0278-5846(98)00033-5_BIB35","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1021\/bi00458a003","article-title":"Organization and expression of the rat D2A receptor gene: Identification of alternative transcripts and a variant donor splice site","volume":"29","author":"O'Malley","year":"1990","journal-title":"Biochemistry"},{"key":"10.1016\/S0278-5846(98)00033-5_BIB36","series-title":"The Rat Brain in Stereotaxic Coordinates","author":"Paxinos","year":"1982"},{"key":"10.1016\/S0278-5846(98)00033-5_BIB37","doi-asserted-by":"crossref","first-page":"R5","DOI":"10.1016\/0014-2999(95)00408-D","article-title":"Absence of detectable striatal dopamine D4 receptors in drug-treated schizophrenia","volume":"281","author":"Reynolds","year":"1995","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/S0278-5846(98)00033-5_BIB38","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0922-4106(95)90169-8","article-title":"Long-term haloperidol elevates dopamine D4 receptors by 2-fold in rats","volume":"289","author":"Schoots","year":"1995","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/S0278-5846(98)00033-5_BIB39","first-page":"229","article-title":"Brain dopamine receptors","volume":"32","author":"Seeman","year":"1980","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/S0278-5846(98)00033-5_BIB40","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/365441a0","article-title":"Dopamine D4 receptors elevated in schizophrenia","volume":"365","author":"Seeman","year":"1993","journal-title":"Nature"},{"key":"10.1016\/S0278-5846(98)00033-5_BIB41","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/261717a0","article-title":"Antipsychotic drug doses and neuroleptic\/dopamine receptors","volume":"261","author":"Seeman","year":"1976","journal-title":"Nature"},{"key":"10.1016\/S0278-5846(98)00033-5_BIB42","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0014-2999(93)90365-O","article-title":"Dopamine D4 receptors bind inactive (+)-aporphines, suggesting neuroleptic role; Sulpiride not stereoselective","volume":"233","author":"Seeman","year":"1993","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/S0278-5846(98)00033-5_BIB43","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/347146a0","article-title":"Molecular cloning and characterization of a novel dopamine receptor: D3 as a target for neuroleptics","volume":"347","author":"Sokoloff","year":"1990","journal-title":"Nature"},{"key":"10.1016\/S0278-5846(98)00033-5_BIB44","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0006-8993(95)00301-6","article-title":"Dopamine D4 receptors and effects of guanine nucleotides on [3H]raclopride binding in postmortem caudate nucleus of subjects with schizophrenia or major depression","volume":"681","author":"Sumiyoshi","year":"1995","journal-title":"Brain Res."},{"key":"10.1016\/S0278-5846(98)00033-5_BIB45","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0304-3940(95)12021-U","article-title":"Genomic structure and tissue distribution of the mouse dopamine D4 receptor","volume":"199","author":"Suzuki","year":"1995","journal-title":"Neurosci. Lett."},{"key":"10.1016\/S0278-5846(98)00033-5_BIB46","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0306-4522(97)00386-2","article-title":"Localization of dopamine receptor subtypes in caudate-putamen and nucleus accumbens septi of rat brain: Comparison of D1-, D2-, and D4-like receptors","volume":"83","author":"Tarazi","year":"1998","journal-title":"Neuroscience"},{"key":"10.1016\/S0278-5846(98)00033-5_BIB47","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/S0306-4522(96)00631-8","article-title":"Differential regulation of dopamine receptors following chronic typical and atypical antipsychotic drug treatment","volume":"78","author":"Tarazi","year":"1997","journal-title":"Neuroscience"},{"key":"10.1016\/S0278-5846(98)00033-5_BIB48","doi-asserted-by":"crossref","first-page":"3423","DOI":"10.1097\/00001756-199711100-00001","article-title":"Regional distribution of dopamine D4 receptors in rat forebrain","volume":"8","author":"Tarazi","year":"1997","journal-title":"NeuroReport"},{"key":"10.1016\/S0278-5846(98)00033-5_BIB49","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/S0893-133X(97)00046-8","article-title":"Long-term effects of S(+)N-n-propylnorapomorphine compared with typical and atypical antipsychotics: Differential increases of cerebrocortical D2-like and striatolimbic D4-like dopamine receptors","volume":"17","author":"Tarazi","year":"1997","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/S0278-5846(98)00033-5_BIB50","first-page":"262","article-title":"Pharmacologically induced behavioural supersensitivity to apomorphine","volume":"245","author":"Tarsy","year":"1973","journal-title":"Nature"},{"key":"10.1016\/S0278-5846(98)00033-5_BIB51","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1038\/350610a0","article-title":"Cloning of a human dopamine D4 receptor gene with high affinity for the antipsychotic clozapine","volume":"350","author":"Van Tol","year":"1991","journal-title":"Nature"},{"key":"10.1016\/S0278-5846(98)00033-5_BIB52","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1046\/j.1471-4159.1995.64020700.x","article-title":"Identification of D3 receptors in the rat striatum and nucleus accumbens using (\u00b1)-7-hydroxy-N,N-di-n-[3H]propyl-2-aminotetralin and carbetapentane","volume":"64","author":"Wallace","year":"1995","journal-title":"J. Neurochem."}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584698000335?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584698000335?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,1,8]],"date-time":"2020-01-08T11:11:44Z","timestamp":1578481904000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584698000335"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,5]]},"references-count":52,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1998,5]]}},"alternative-id":["S0278584698000335"],"URL":"https:\/\/doi.org\/10.1016\/s0278-5846(98)00033-5","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[1998,5]]}}}